irasia.com - Investor Relations Asia Pacific
HOME

CSPC Pharmaceutical Group Limited
(Incorporated in Hong Kong with limited liability)

Documents on Display       


Please download the latest "Acrobat Reader" to view the PDF.

DOCUMENTS ON DISPLAY FOR THE WHITEWASH WAIVER CIRCULAR

  • (001) Articles of Association (English)
  • (002) Articles of Association (Chinese)
  • (003) Annual Report 2020 (English)
  • (004) Annual Report 2020 (Chinese)
  • (005) Annual Report 2021 (English)
  • (006) Annual Report 2021 (Chinese)
  • (007) Annual Report 2022 (English)
  • (008) Annual Report 2022 (Chinese)
  • (009) Interim Report 2023 (English)
  • (010) Interim Report 2023 (Chinese)
  • (011) Letter from the Board (English)
  • (012) Letter from the Board (Chinese)
  • (013) Letter from the Independent Board Committee (English)
  • (014) Letter from the Independent Board Committee (Chinese)
  • (015) Letter from the Independent Financial Adviser
  • (016) Written Consent from the Independent Financial Adviser
  • (017) Service contract of Chen Chuan (Chinese)
  • (018) Service contract of Wang Bo (Chinese)
  • (019) Circular (English)
  • (020) Circular (Chinese)
  • updated 9th October, 2023


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2023 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.
    Cookie Policy

    This website uses cookies. Please refer to our Cookie Notice and Privacy Notice for further information. By continuing to use this website, you agree to our use of cookies.

    Close